tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

VIGL Stock Latest News

Vigil Neuroscience Advances Key Clinical Programs
Company AnnouncementsVigil Neuroscience Advances Key Clinical Programs
15d ago
VIGL
Vigil Neuroscience reports Q3 EPS (47c), consensus (54c)
PremiumThe Fly
Vigil Neuroscience reports Q3 EPS (47c), consensus (54c)
16d ago
VIGL
Vigil Neuroscience story ‘gaining momentum,’ says Jefferies
PremiumThe Fly
Vigil Neuroscience story ‘gaining momentum,’ says Jefferies
2M ago
VIGL
Vigil Neuroscience Advances Alzheimer’s Trial, Eyes 2025 Data
PremiumCompany Announcements
Vigil Neuroscience Advances Alzheimer’s Trial, Eyes 2025 Data
2M ago
8K
VIGL
Vigil Neuroscience announces FDA removed partial clinical hold on VG-3927
PremiumThe Fly
Vigil Neuroscience announces FDA removed partial clinical hold on VG-3927
2M ago
VIGL
Vigil Neuroscience price target lowered to $16 from $17 at Guggenheim
PremiumThe FlyVigil Neuroscience price target lowered to $16 from $17 at Guggenheim
3M ago
VIGL
Vigil Neuroscience sees cash runway into 2026
Premium
The Fly
Vigil Neuroscience sees cash runway into 2026
3M ago
VIGL
Vigil Neuroscience reports Q2 EPS (52c), consensus (55c)
Premium
The Fly
Vigil Neuroscience reports Q2 EPS (52c), consensus (55c)
3M ago
VIGL
Vigil Neuroscience publishes new data on CSF1R gene variants
PremiumThe Fly
Vigil Neuroscience publishes new data on CSF1R gene variants
4M ago
VIGL
Vigil Neuroscience’s Promising Phase 1 Trial and Alzheimer’s Focus
PremiumCompany Announcements
Vigil Neuroscience’s Promising Phase 1 Trial and Alzheimer’s Focus
4M ago
8K
VIGL
Vigil Neuroscience announces interim data from ongoing Phase 1 trial on VG-3927
PremiumThe Fly
Vigil Neuroscience announces interim data from ongoing Phase 1 trial on VG-3927
4M ago
VIGL
Vigil Neuroscience price target lowered to $17 from $24 at H.C. Wainwright
PremiumThe Fly
Vigil Neuroscience price target lowered to $17 from $24 at H.C. Wainwright
4M ago
VIGL
Vigil Neuroscience Advances IGNITE Trial, Eyes Accelerated Approval
PremiumCompany AnnouncementsVigil Neuroscience Advances IGNITE Trial, Eyes Accelerated Approval
4M ago
8K
VIGL
Vigil Neuroscience updates clinical development strategy for iluzanebart in ALSP
Premium
The Fly
Vigil Neuroscience updates clinical development strategy for iluzanebart in ALSP
4M ago
VIGL
Vigil Neuroscience price target raised to $23 from $22 at Wedbush
Premium
The Fly
Vigil Neuroscience price target raised to $23 from $22 at Wedbush
5M ago
VIGL
Sanofi investing $400M in Vigil Neuroscience, says Guggenheim
PremiumThe Fly
Sanofi investing $400M in Vigil Neuroscience, says Guggenheim
5M ago
SNY
VIGL
Vigil Neuroscience announces $40M investment from Sanofi
PremiumThe Fly
Vigil Neuroscience announces $40M investment from Sanofi
5M ago
SNY
VIGL
These 2 ‘Strong Buy’ Penny Stocks Are Poised for a Massive Rally, Say Analysts
PremiumStock Analysis & Ideas
These 2 ‘Strong Buy’ Penny Stocks Are Poised for a Massive Rally, Say Analysts
6M ago
SCPH
VIGL
Vigil Neuroscience reports Q1 EPS (50c), consensus (61c)
PremiumThe Fly
Vigil Neuroscience reports Q1 EPS (50c), consensus (61c)
7M ago
VIGL
Vigil says interim IGNITE Phase 2 data demonstrate VGL101 potential for ALSP
PremiumThe FlyVigil says interim IGNITE Phase 2 data demonstrate VGL101 potential for ALSP
7M ago
VIGL
Vigil Neuroscience’s Funding Peril: Navigating Market Turbulence in Equity Capital Raises
Premium
Company Announcements
Vigil Neuroscience’s Funding Peril: Navigating Market Turbulence in Equity Capital Raises
8M ago
VIGL
Vigil Neuroscience sees cash runway into 2H25
Premium
The Fly
Vigil Neuroscience sees cash runway into 2H25
8M ago
VIGL

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >